Haemonetics Corp. (NYSE: HAE) Shares Downgraded at CJS Securities

Shares of Haemonetics Corp. (NYSE: HAE) were downgraded by analysts at CJS Securities in a note to their investors today. The company currently has a rating of Market Perform on the stock. The one-year price target of $35.00 is lower than the opening price of $36.79, resulting a number of other analysts to comment on the stock recently. Looking back over the last 52 weeks, Haemonetics Corp. stock has a high of $38.06. considerable and major changes in the company’s procedures, future ision or industry can cause downgrades as the analysts believe that the future prospects for the security have diminished from the initial recommendation.

U.S. stocks on Monday closed essentially flat, after trading firmly higher, in a volatile session ahead of the start of a pair of closely watched central-bank policy meetings.

The Dow Jones Industrial Average DJIA, -0.02% closed down 3.63 points at 18,120.17.

The blue-chip index had been up by as much as 131 points earlier and traded within a 162-point range.

The S&P 500 SPX, +0.00% slipped 0.04 points to close at 2,139.12, after trading within an 18-point range

Meanwhile, the Nasdaq Composite Index COMP, -0.18% declined 9.54 points, or 0.2%, to close at 5,235.03.

Earlier, the Nasdaq Composite Index had been up by as many as 37 points and traded with a 58-point range

Shares of Haemonetics Corp. (NYSE: HAE) opened at $36.79 yesterday trading between $36.59 and $37.01, and last traded at $36.91, a decrease of $0.32 from the previous closing price.

Haemonetics Corp. (NYSE: HAE) now has a market cap of 1.89B.

The stock’s average daily volume is 334,956 shares out of a total float 50,966,000 and some 88,229 shares crossed the trading desk yesterday, 38 percent below the average. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to determine heavy volume growth or dissemination by institutional investors.

As with all possible breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain substantial teams of analysts that investigate thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.

Trades for Haemonetics Corp. (NYSE: HAE) have ranged from $25.98 – 38.06, and the stock now has a 50-day MA of $36.22 and 200-day MA of $32.19. Today’s last price is 0.03% under the 52 week high of $38.06.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors seek companies that have grown their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.